Literature DB >> 24174619

Substrate-induced protein stabilization reveals a predominant contribution from mature proteins to peptides presented on MHC class I.

Jeff D Colbert1, Diego J Farfán-Arribas, Kenneth L Rock.   

Abstract

The origin of the MHC class I-presented peptides are thought to be primarily from newly synthesized but defective proteins, termed defective ribosomal products. Most of the data supporting this concept come from studies in which inhibitors of protein synthesis were found to rapidly block Ag presentation even when cells contained a pool of mature proteins. However, these data only indirectly address the origin of presented peptides, and in most studies, the contribution of mature functional proteins to the class I peptide pool has not been directly quantified. In this report, we address the efficiency and contribution of mature proteins using a tetracycline-inducible system to express Ags that are conditionally stabilized upon ligand binding. This system circumvents the use of general inhibitors of protein synthesis to control Ag expression. Moreover, by controlling Ag stabilization, we could investigate whether the degradation of mature Ags contributed to Ag presentation at early and/or late time points. We show that mature proteins are the major contributor of peptides presented on class I for two distinct antigenic constructs. Furthermore, our data show that the protein synthesis inhibitors used previously to test the contribution of defective proteins actually block Ag presentation in ways that are independent from blocking Ag synthesis. These data suggest that for the constructs we have analyzed, mature functional proteins, rather than defective ribosomal products, are the predominant source of MHC class I-presented peptides.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24174619      PMCID: PMC3845381          DOI: 10.4049/jimmunol.1300078

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  Protein synthesis upon acute nutrient restriction relies on proteasome function.

Authors:  Ramunas M Vabulas; F Ulrich Hartl
Journal:  Science       Date:  2005-12-23       Impact factor: 47.728

2.  Tight linkage between translation and MHC class I peptide ligand generation implies specialized antigen processing for defective ribosomal products.

Authors:  Shu-Bing Qian; Eric Reits; Jacques Neefjes; Jeanne M Deslich; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

3.  A role for intercellular antigen transfer in the recognition of EBV-transformed B cell lines by EBV nuclear antigen-specific CD4+ T cells.

Authors:  Graham S Taylor; Heather M Long; Tracey A Haigh; Martin Larsen; Jill Brooks; Alan B Rickinson
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

4.  The turnover kinetics of major histocompatibility complex peptides of human cancer cells.

Authors:  Elena Milner; Eilon Barnea; Ilan Beer; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2005-11-04       Impact factor: 5.911

Review 5.  Intracellular protein degradation in mammalian and bacterial cells: Part 2.

Authors:  A L Goldberg; A C St John
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

6.  Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pinocytic vesicles.

Authors:  C Y Okada; M Rechsteiner
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

7.  Cross-priming utilizes antigen not available to the direct presentation pathway.

Authors:  Keri B Donohue; Jean M Grant; Eric F Tewalt; Douglas C Palmer; Marc R Theoret; Nicholas P Restifo; Christopher C Norbury
Journal:  Immunology       Date:  2006-06-08       Impact factor: 7.397

8.  A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.

Authors:  Laura A Banaszynski; Ling-Chun Chen; Lystranne A Maynard-Smith; A G Lisa Ooi; Thomas J Wandless
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

9.  The 2.1A crystal structure of copGFP, a representative member of the copepod clade within the green fluorescent protein superfamily.

Authors:  Pascal G Wilmann; Jion Battad; Jan Petersen; Matthew C J Wilce; Sophie Dove; Rodney J Devenish; Mark Prescott; Jamie Rossjohn
Journal:  J Mol Biol       Date:  2006-04-25       Impact factor: 5.469

10.  Influence of translation efficiency of homologous viral proteins on the endogenous presentation of CD8+ T cell epitopes.

Authors:  Judy Tellam; Mark H Fogg; Michael Rist; Geoff Connolly; David Tscharke; Natasha Webb; Lea Heslop; Fred Wang; Rajiv Khanna
Journal:  J Exp Med       Date:  2007-02-20       Impact factor: 14.307

View more
  13 in total

Review 1.  Re-examining class-I presentation and the DRiP hypothesis.

Authors:  Kenneth L Rock; Diego J Farfán-Arribas; Jeff D Colbert; Alfred L Goldberg
Journal:  Trends Immunol       Date:  2014-02-21       Impact factor: 16.687

Review 2.  Connexins and pannexins in the immune system and lymphatic organs.

Authors:  Aaron M Glass; Elizabeth G Snyder; Steven M Taffet
Journal:  Cell Mol Life Sci       Date:  2015-06-23       Impact factor: 9.261

Review 3.  Lymphocyte repertoire selection and intracellular self/non-self-discrimination: historical overview.

Authors:  Donald R Forsdyke
Journal:  Immunol Cell Biol       Date:  2014-11-11       Impact factor: 5.126

4.  Kinetically distinct processing pathways diversify the CD8+ T cell response to a single viral epitope.

Authors:  Gabriela L Cosma; Jenna L Lobby; Elizabeth J Fay; Nicholas A Siciliano; Ryan A Langlois; Laurence C Eisenlohr
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

5.  Alternative Start Sites Downstream of Non-Sense Mutations Drive Antigen Presentation and Tolerance Induction to C-Terminal Epitopes.

Authors:  Scott N Ashley; Suryanarayan Somanathan; Christian Hinderer; Maxwell Arias; Deirdre McMenamin; Christine Draper; James M Wilson
Journal:  J Immunol       Date:  2017-05-12       Impact factor: 5.422

6.  The nature and extent of contributions by defective ribosome products to the HLA peptidome.

Authors:  Dmitry Bourdetsky; Christian E H Schmelzer; Arie Admon
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-08       Impact factor: 11.205

Review 7.  Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum.

Authors:  Nilabh Shastri; Niranjana Nagarajan; Kristin C Lind; Takayuki Kanaseki
Journal:  Curr Opin Immunol       Date:  2013-12-11       Impact factor: 7.486

Review 8.  Understanding the biology of antigen cross-presentation for the design of vaccines against cancer.

Authors:  Cynthia M Fehres; Wendy W J Unger; Juan J Garcia-Vallejo; Yvette van Kooyk
Journal:  Front Immunol       Date:  2014-04-08       Impact factor: 7.561

Review 9.  Effects of messenger RNA structure and other translational control mechanisms on major histocompatibility complex-I mediated antigen presentation.

Authors:  Pierre Murat; Judy Tellam
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-09-26       Impact factor: 9.957

10.  Remote and reversible inhibition of neurons and circuits by small molecule induced potassium channel stabilization.

Authors:  Eva Auffenberg; Angela Jurik; Corinna Mattusch; Rainer Stoffel; Andreas Genewsky; Christian Namendorf; Roland M Schmid; Gerhard Rammes; Martin Biel; Manfred Uhr; Sven Moosmang; Stylianos Michalakis; Carsten T Wotjak; Christoph K Thoeringer
Journal:  Sci Rep       Date:  2016-01-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.